• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Case Rep . Guillain-Barre syndrome secondary to COVID-19 infection: A case report

tetano

Editor, Senior Moderator
Clin Case Rep


. 2023 Mar 30;11(4):e7104.
doi: 10.1002/ccr3.7104. eCollection 2023 Apr.
Guillain-Barre syndrome secondary to COVID-19 infection: A case report


Dena H Tran[SUP] 1 [/SUP], Dalwinder Basra[SUP] 2 [/SUP], Zaid Bilgrami[SUP] 3 [/SUP], Suryanarayana R Challa[SUP] 3 [/SUP], Christina Kwon[SUP] 3 [/SUP], Ellen Marciniak[SUP] 1 [/SUP], Avelino C Verceles[SUP] 1 [/SUP]



Affiliations

Abstract

Guillain-Barre syndrome (GBS) is a rare autoimmune disease that often manifests as a post-viral complication. However, its association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. We present a rare case of GBS secondary to COVID-19 infection complicated by rapidly progressive sensorimotor deterioration resistant to plasma exchange therapy.

Keywords: COVID‐19; Guillain‐Barre syndrome; SARS‐CoV‐2; autoimmune disease; case report; cerebrospinal fluid; demyelination.
 
Back
Top Bottom